Retatrutide for Seniors Over 65

Obesity in adults over 65 presents a clinical paradox. On one hand, excess weight worsens nearly every age-related condition: arthritis becomes more painful, heart failure is exacerbated, diabetes control deteriorates, and mobility declines faster. On the other hand, the "obesity paradox" suggests that moderate overweight (BMI 25-30) in older adults may be protective against certain conditions, and intentional weight loss in seniors carries real risks of sarcopenia, falls, fractures, and malnutrition. Navigating this tension requires individualized treatment goals that prioritize function over numbers on a scale. Retatrutide's Phase 2 data (Jastreboff et al., NEJM 2023) is promising, but its application in seniors demands careful consideration.

Sarcopenic Obesity: The Central Challenge

Sarcopenic obesity -- the combination of excess fat and inadequate muscle mass -- is the defining challenge of weight management in seniors. Older adults naturally lose 3-8% of muscle mass per decade after age 30, accelerating after 60. Adding weight loss to this baseline muscle decline can produce dangerous functional impairment. Falls risk increases as leg strength decreases. Activities of daily living (climbing stairs, rising from chairs, carrying groceries) become harder. Immune function can decline with inadequate nutrition. And recovery from illness or surgery is impaired.

The treatment goal for seniors is not maximum weight loss but rather fat loss with muscle preservation -- improving body composition rather than simply reducing scale weight. Muscle preservation strategies are absolutely essential.

A Modified Approach for Seniors

• Slower dose titration: Start at the lowest possible dose and titrate more slowly to minimize GI side effects and dehydration risk.
• Moderate weight loss targets: Aim for 10-15% weight loss rather than maximum weight loss, focusing on functional improvement.
• High protein priority: Protein intake of 1.2-1.6 g/kg/day is essential, with emphasis on leucine-rich sources.
• Resistance training: Supervised resistance training 2-3 times weekly, appropriate for fitness level.
• Hydration vigilance: Seniors are more susceptible to dehydration from GI side effects. Hydration monitoring is critical.
• Medication review: GLP-1 medications interact with many common senior medications through delayed gastric emptying. Complete medication review is necessary.
• Bone density monitoring: DEXA scan before and during treatment, with calcium and vitamin D supplementation.

Quality of Life Benefits

For seniors with obesity-related functional limitations, even moderate weight loss can produce dramatic quality of life improvements. Reduced joint pain enables more physical activity, creating a positive cycle. Improved cardiovascular capacity allows participation in social activities. Better blood sugar control reduces diabetes complications and improves energy. And improved sleep (including sleep apnea resolution) enhances daytime function and mood.

Start Treatment Carefully

Compounded semaglutide ($99/mo) and compounded tirzepatide ($125/mo) can be prescribed for seniors with appropriate medical supervision and modified treatment goals.